Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
Fallopian Tube Cancer Clinical Trials
A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Arizona
Glendale : Arizona Center for Cancer Care Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Peoria : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Phoenix : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Phoenix : St. Joseph's Hospital and Medical Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
View More »
Scottsdale :
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Scottsdale : Pinnacle Oncology Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Tucson : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
California
Bakersfield : Comprehensive Blood and Cancer Center Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Berkeley : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Concord : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Corona : Wilshire Oncology Medical Group Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Corona : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Long Beach : Long Beach Memorial Medical Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Los Angeles :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Los Angeles : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Oceanside : North County Oncology Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Oxnard : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Rancho Mirage : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
San Francisco : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Santa Maria : Central Coast Medical Oncology Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Colorado
Englewood : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Connecticut
Hartford : St. Francis Hospital and Medical Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
New Britain : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New Britain : The Hospital of Central Connecticut Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Norwalk : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Stamford : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Florida
Georgia
Savannah : Memorial University Medical Center
GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
View More »
Augusta : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Macon : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Illinois
Hinsdale : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hinsdale : Sudarshan K. Sharma, MD, LTD Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Joilet :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Indiana
Indianapolis : Indiana University Simon Cancer Center Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Indianapolis : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Lafayette :
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Iowa
Ames : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ames : McFarland Clinic Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Louisiana
Covington :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Maryland
Massachusetts
Boston : Massachusetts General Hospital
Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Boston : Dana-Farber Cancer Institute
Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Michigan
Ann Arbor : St. Joseph Mercy Hospital Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Kalamazoo : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kalamazoo : West Michigan Cancer Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Minnesota
Rochester : Mayo Clinic
Accelerating Gastrointestinal Recovery
St. Louis Park : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
St. Louis Park : Park Nicollet Frauenshuh Cancer Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Mississippi
Jackson : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Jackson : University of Mississippi Medical Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Jackson : St. Dominic-Jackson Memorial Hospital Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Missouri
Montana
Billings : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Nevada
Las Vegas : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Las Vegas : Women's Cancer Care Center of Nevada Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Reno : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New Jersey
Camden : Cooper Health System / Cooper Cancer Institute Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Hackensack : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Voorhees : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New Mexico
Albuquerque : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New York
New York : Biomedical Research Alliance of New York
Ovarian/Fallopian/Primary Peritoneal Cancer
View More »
Albany : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Albany : Women's Cancer Care Associates Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Bridgewater :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Brightwaters : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Brooklyn : SUNY Downstate Medical Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Buffalo :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
New York :
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
New York : Bellevue Hospital Center (NYU Langone Medical Center affiliate)
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
New York : New York University Clinical Cancer Center
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
New York : Columbia University Medical Center
Neoadjuvant Therapy for Ovarian Cancer
New York : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
North Carolina
Asheville : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Burlington : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Burlington : Alamance Regional Cancer Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Charlotte : Carolinas Medical Center/Blumenthal Cancer Center Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Charlotte : Carolinas Medical Center / Levine Cancer Institute Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
View More »
Concord : Carolinas Medical Center - Northeast Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Durham :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Durham : Duke Cancer Institute
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Winston Salem : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ohio
Akron : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kettering : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Toledo : ProMedica Health System, Inc. Updated
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Oklahoma
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Oklahoma City :
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Oklahoma City : University of Oklahoma
Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Oklahoma City : University of Oklahoma Health Sciences Center
Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer
Oklahoma City : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Oklahoma City : Peggy and Charles Stephenson Cancer Center Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Tulsa : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Tulsa : Tulsa Cancer Institute Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Oregon
Bend : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Pennsylvania
Abington :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Abington : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Abington : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Abington : Abington Memorial Hospital; Hanjani Institute for Gynecologic Oncology Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Bethlehem : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Philadelphia :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Philadelphia : Fox Chase Cancer Center
MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
Philadelphia : Fox Chase Cancer Center
Neoadjuvant Therapy for Ovarian Cancer
Philadelphia : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Pittsburgh : Magee-Womens Hospital of UPMC
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Pittsburgh : Magee-Womens Hospital of UPMC
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Pittsburgh : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Pittsburgh : Western Pennsylvania Hospital Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Rhode Island
Providence : Women & Infants' Hospital
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Providence : Women and Infants Hospital of Rhode Island Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
South Carolina
Greenville : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Greenville : Bon Secours St. Francis Hospital Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
South Dakota
Sioux Falls : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Sioux Falls : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Tennessee
Texas
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Austin : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Bedford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Bedford : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Dallas : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Ft. Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Galveston : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Houston : UT MD Anderson Cancer Center
First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Houston : The University of Texas MD Anderson Cancer Center
MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
San Antonio : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Utah
Ogden : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Vermont
Burlington : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Virginia
Annandale : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Annandale : Mid Atlantic Pelvic Surgery Associates Updated
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Charlottesville : University of Virginia
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Charlottesville : University of Virginia
Neoadjuvant Therapy for Ovarian Cancer
Norfolk : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Woodbridge : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Washington
Seattle : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Wenatchee : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Wisconsin
Green Bay : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Green Bay : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Milwaukee : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Oshkosh : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Sheboygan : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Wausau : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
West Allis : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Australia
Auchenflower : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Footscray : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
New Lambton Heights : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Parkville : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Wahroonga : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Austria
Graz : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Graz : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Innsbruck : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Innsbruck : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Linz : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
View More »
Linz : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Salzburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Wien : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Wien : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Belarus
Gomel : Gomel Regional Clincial Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Minsk : Alexandrov National Cancer Center of Belarus
Study of Paclitaxel in Patients With Ovarian Cancer
Minsk : Minsk City Clinical Oncology Hospital
Study of Paclitaxel in Patients With Ovarian Cancer
Vitebsk : Vitebsk Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Belgium
Bonheiden : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Brasschaat : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Charleroi : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Charleroi : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Duffel : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Edegem : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Edegem : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Gent : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Gent : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hasselt : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ieper : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Kortrijk : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Leuven : Department of gyneacology, Campus Gasthuisberg
Study of Paclitaxel in Patients With Ovarian Cancer
Leuven : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Leuven : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Liège : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Liège : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Libramont : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Libramont : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Namur : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Namur : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Oostende : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Sint-Niklaas : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Turnhout : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Wilrijk : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Yvoir : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Brazil
Barretos : Hospital de Câncer de Barretos Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Belo Horizonte : Oxion Hospital Dia Oncologia Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Curitiba : Hospital Erasto Gaertner Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Florianópolis : CEPON - Centro de Pesquisas Oncológicas de Santa Catarina Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Jaú : Fundação Amaral Carvalho Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
View More »
Porto Alegre : Hospital de Clínicas de Porto Alegre Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Rio de Janeiro : INCA - Instituto Nacional de Câncer Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Salvador : Núcleo de Oncologia da Bahia Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
São Paulo : Hospital Israelita Albert Einstein Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
São Paulo : Hospital Santa Marcelina Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
São Paulo : Instituto do Câncer do Estado de São Paulo "Octávio Frias de Oliveira" Updated
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Bulgaria
Shumen : Regional Oncology Dispensary
Study of Paclitaxel in Patients With Ovarian Cancer
Sofia : Hospital for a Active Treatment, Tsaritsa Yoanna
Study of Paclitaxel in Patients With Ovarian Cancer
Stara Zagora : Regional Oncology Dispensary
Study of Paclitaxel in Patients With Ovarian Cancer
Canada
Calgary : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Edmonton : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Halifax : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hamilton :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Kingston : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
London : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Montreal : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Quebec : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Sault Ste. Marie : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Toronto :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Toronto : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Croatia
Rijeka : Klinički Bolnički Centar Rijeka
Study of Paclitaxel in Patients With Ovarian Cancer
Split : Klinički Bolnički Centar Split
Study of Paclitaxel in Patients With Ovarian Cancer
Czech Republic
Denmark
Herlev : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Herlev : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Herning : Onkologisk Afdelning, Herning Sygehus
Study of Paclitaxel in Patients With Ovarian Cancer
København : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
København Ø : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Roskilde : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Finland
Germany
Aalen : Ostalbklinikum
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Berlin : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Düsseldorf : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Dresden : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Erlangen : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Essen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Essen : University hospital, Dept. of gynecology & obstetrics
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Essen : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Essen : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Esslingen : Klinikum Esslingen
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Frankfurt : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Frankfurt am Main : Klinikum der JWG Universität Frankfurt
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Frankfurt am Main : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Freiburg : Universitätsklinikum Freiburg, Frauenklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Freiburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Hamburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hannover : Medizinische Hochschule
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Hannover : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Kiel : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Konstanz : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ludwigsburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
München : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Mainz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Offenburg : St. Josefsklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Paderborn : St. Vincenz-Krankenhaus
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Ravensburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Rostock : Klinikum Südstadt
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Rostock : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Rostock : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Stuttgart : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Tübingen : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ulm : Universitätsklinikum, Universitätsfrauenklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Ulm : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Wiesbaden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Wolfsburg : Klinikum der Stadt Wolfsburg
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Greece
Athens : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Thessaloniki : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hong Kong
Hong Kong : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Hong Kong : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kowloon : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New Territories : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
New Territories : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Hungary
Italy
Avellino : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Aviano PN : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Bologna : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Brescia : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Campobasso : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
View More »
Genova : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Milano : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Milano : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Napoli : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Napoli : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Novara : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Palermo : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Pisa : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Roma : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Roma : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Torino : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Japan
Fukuoka-shi : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kashiwa : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kitaadachi-gun : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kure-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kurume-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Morioka-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Nagoya-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Sapporo-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Suntou-gun : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Tokyo : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Yonago-city : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Korea, Republic of
Goyang-si, Gyeonggi-do : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Seoul : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Latvia
Lithuania
Netherlands
Deventer : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Leiden : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Nijmegen : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Rotterdam : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
New Zealand
Tauranga : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Romania
Cluj Napoca : Cluj CF University Hospital
Study of Paclitaxel in Patients With Ovarian Cancer
Constanta : Constanta Clinical County Hospital
Study of Paclitaxel in Patients With Ovarian Cancer
Craiova : MEDITECH SRL, ORIZONT Polyclinic
Study of Paclitaxel in Patients With Ovarian Cancer
Oradea : County Clinical Emergency Hospital Oradea
Study of Paclitaxel in Patients With Ovarian Cancer
Russian Federation
Arkhangelsk : State Medical Institution, Arkhankelsk Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Barnaul : State Medical Institution, Altai Regional Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Chelyabinsk : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Ekaterinburg : State Budget-funded Medical Institution of Sverdlovsk Region "Sverdlovsk Regional Oncology Center"
Study of Paclitaxel in Patients With Ovarian Cancer
View More »
Ivanovo : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Kazan : Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Kirov : State Treatment and Prevention Institution, Kirov Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Krasnodar : State Medical Institution "Clinical Oncology Center #1" under the Ministry of Health of Krasnodar Region
Study of Paclitaxel in Patients With Ovarian Cancer
Krasnodar : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Magnitogorsk : State Medical Institution, Regional Oncology Center #2, Surgery department
Study of Paclitaxel in Patients With Ovarian Cancer
Moscow : N.N. Blokhin Cancere Research Center under the Russian Academy of Medical Sciences
Study of Paclitaxel in Patients With Ovarian Cancer
Moscow : Federal State Institution, Central Clinical Hospital with Outpatient Unit under the Russian Presidential Administration
Study of Paclitaxel in Patients With Ovarian Cancer
Moscow : State Institution, Moscow City Oncology Hospital #62
Study of Paclitaxel in Patients With Ovarian Cancer
Moscow : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Nizhniy Novgorod : Federal State Institution "Privolzhskiy District Medical Center of Federal Bio-medical Agency"
Study of Paclitaxel in Patients With Ovarian Cancer
Obninsk : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Omsk : State Medical Institution of the Omsk Region, Clincial Oncology center
Study of Paclitaxel in Patients With Ovarian Cancer
Orenburg, : State Medical Institution "Orenburg Regional Clinical Oncology Center"
Study of Paclitaxel in Patients With Ovarian Cancer
Penza : State Medicinal Institution, Reginal oncology center
Study of Paclitaxel in Patients With Ovarian Cancer
Petrozavodsk : State Medical Institution "Republic Oncology Center"
Study of Paclitaxel in Patients With Ovarian Cancer
Pyatigorsk : Pyatigorsk Affiliate of State Medical Institution, Stavropol Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Saint Petersburg : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Saint-Petersburg, : State Medical Institution "Leningrad Regional Oncology Center"
Study of Paclitaxel in Patients With Ovarian Cancer
Samara : Samara Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Sochi : State Medical Institution, Oncology Center #2 under the Krasnodar Region Healthcare Department
Study of Paclitaxel in Patients With Ovarian Cancer
St Petersburg : St Petersburg State Medical Institution, City clinical oncology center
Study of Paclitaxel in Patients With Ovarian Cancer
St Petersburg : Federal State Medical Institution, N.N. Petrov Research Institute of Oncology under the Federal Agency for High-Tech Medical Care of the Russian Federation, Oncogynecology Department
Study of Paclitaxel in Patients With Ovarian Cancer
Stavropol, : State Medical Institution "Stavropol Regional Clinical Oncology Center"
Study of Paclitaxel in Patients With Ovarian Cancer
Tambov : State Medical Institution, Tambov Regional Oncology Center #2
Study of Paclitaxel in Patients With Ovarian Cancer
Ufa : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Voronezh : State Medical Institution, Voronezh Regional Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Voronezh : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Yaroslavl : State Medical Institution of the Yaroslavl, Region Clinical Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Serbia
Singapore
Singapore : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Slovakia
Banska Bysterica : Onkologicke oddelenie, FNsP F. D. Roosevelta
Study of Paclitaxel in Patients With Ovarian Cancer
Bratilslava : Interne oddelenie, Narodny onkologicky ustav
Study of Paclitaxel in Patients With Ovarian Cancer
Bratislava : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Kosice : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Presov : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
View More »
Simferopol : Crimean Republicann Oncology Dispensary
Study of Paclitaxel in Patients With Ovarian Cancer
Spain
Badalona : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Barcelona : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Lleida : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Madrid : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Oviedo : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
View More »
Palma de Mallorca : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Valencia : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Zaragoza : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Sweden
Taiwan
Tainan : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Taipei : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Ukraine
Cherkassy : Cherkassy Regional Oncological Centre
Study of Paclitaxel in Patients With Ovarian Cancer
Chernivtsy : Cherkassy Regional Oncological Centre
Study of Paclitaxel in Patients With Ovarian Cancer
Dnepropetrovsk : KZ, City Clinical Hospital #19 City oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Dnipropetrovsk : Multi-profile clinical hospital#4
Study of Paclitaxel in Patients With Ovarian Cancer
Donetsk : Donetsk Regional Antitumor Center
Study of Paclitaxel in Patients With Ovarian Cancer
View More »
Ivano-Frankivsk, 76018 : Ivano-Frankivsk Regional Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Kharkiv : Kharkiv Regional Clinical Oncology
Study of Paclitaxel in Patients With Ovarian Cancer
Kharkiv : "S.P. Grygoryev Institute of Medical Radiology of the Academy of Medical Science of Ukraine
Study of Paclitaxel in Patients With Ovarian Cancer
Kherson : Kherson Reginal Oncological Center
Study of Paclitaxel in Patients With Ovarian Cancer
Kiev : Kiev City Oncology center
Study of Paclitaxel in Patients With Ovarian Cancer
Kiev : DU, National Institute of Cancer, Department of Oncogynecology
Study of Paclitaxel in Patients With Ovarian Cancer
Kyiv : Kyiv Regional Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Lugansk : Lugansk Regional Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Odessa : Odessa City Oncological Center
Study of Paclitaxel in Patients With Ovarian Cancer
Sumy : Sumy Regional Onclolgy Center
Study of Paclitaxel in Patients With Ovarian Cancer
Ternopil : Ternopil Regional Oncology Hospital
Study of Paclitaxel in Patients With Ovarian Cancer
United Kingdom
London : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Manchester : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Northwood : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Nottingham : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
Poole : Research Site
TRINOVA-2: Trebananib in Ovarian Cancer-2
